Separate names with a comma.
Discussion in 'Novartis' started by Anonymous, Apr 21, 2011 at 9:17 PM.
Biogen owns MS. BG12 will get priority review and be available soon
The Serono rep said the same thing. Wow Biogen owns MS how old are you 10?
Hum. Put them on something as safe as bg 12 or put them on Gilenya. There's a hard answer! Once again, you leave and this is what happens. For the loyal who stayed put, bg is their reward. And unlike novartis BIIB is taking real care of their employees. Yesterday I made 70,000 after giving uncle sam 37,000. I'm sure big pharma novartis will do the same for it's employees. The stock will go to 100 in the next 75 years! But don't worry in 3-5 years after physicians determine the long term effects of your drug they might feel comfortable using. So in 1200 days from now let me know how it's going for you. In those 1200 days Biogen will have put you right out of the race. Remember you win some and you lose some.
Good thing for Biogen because Tysabri PML rate is rising fast.
Let's just hope there's no little hidden problems that are discovered "after" it has been rushed to market.
Has anyone considered the unknown of how Gilenya SIGNIFICANTLY lowers the periph lymphocyte count in the body after dosing especially at steady state. That will cause serious illness and many deaths one would think. If I were prescribing this drug, I would be careful and wait it out to find out what results would be. SCARY---I AM JUST SAYING>
Been on the market in Germany for over 10 years. No issues whatsoever. Fty is toast
Actually the rate is not increasing one bit more than 6 months ago. The number of cases increases because the number of patients rise. Tysabri is going nowhere, so get used to it.
Wow - you cannot do math. Patient rise is not so great, but the rate of PML cases is increasing. Nine more cases this month, seven last month, ten the month before that. There was a steady average of five cases per month prior. What you are seeing is a number of patients in the 2-3 year range emerging and that rate is close to 1 in 500.
Not many patients are new to Tysabri and quite a few are dropping the drug.
Read before you speak.
Who are you taking to most of us did not come from Biogen. Your bragging about 70,000 how small is your dick.
Money bags your not running a hedge fund your a sales rep. Where you spending all that money on yacht or a million dollar home let us know.
You're fighting a losing battle on this one - no comprehension of the difference - but you'll get all kinds of vitriolic spew in the meantime.
Look he just make 70k and a spelling expert. Did you pick out your new Mercedes with all that cash?
It's 70 more than any of us are making.
I made a great bonus selling Gilenya. Should make over 60k this year.
You're probably the only one. Ask how many will make under target bonus in a launch year.
I call BULLSHIT. I have a top 10 territory. I'm not making ANYTHING CLOSE TO NET 60,000
Here since launch & I second that. BS for sure
Take a look at the numbers you want my W2. I said I am on pace about 30k when Q2 gets paid out in June.
Ya, ok and I'm looking at Niagra Falls in the middle of the Arizona desert.